Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma

Journal of Biosciences

Volumn 36, Issue 4, 2011, Pages 659-668

  Junrong, Tong ^a   Huancheng, Zhou ^b   Feng, He ^a   Yi, Gao ^b   Xiaoqin, Yang ^c   Zhengmao, Luo ^a   Hong, Zhang ^a   Jianying, Zeng ^a   Yin, Wang ^a   Yuanhang, Huang ^a   Jianlin, Zhang ^a   Longhua, Sun ^a   Guolin, He ^b  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

2 DE; CIB1; hepatocellular carcinoma; proliferation; proteomics

Indexed keywords

BIOLOGICAL MARKER; ONCOPROTEIN; PROTEIN CIB1; UNCLASSIFIED DRUG;

BIOMARKER; ELECTROKINESIS; PROTEIN; PROTEOMICS; RNA; TUMOR;

AMINO ACID SEQUENCE; ARTICLE; CANCER INHIBITION; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; RNA INTERFERENCE; TIME OF FLIGHT MASS SPECTROMETRY; TISSUE STRUCTURE; UPREGULATION; VALIDATION PROCESS;

BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE SILENCING; HEP G2 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NEOPLASM PROTEINS; PROGNOSIS; PROTEOMICS; RNA, SMALL INTERFERING; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL ANALYSIS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 80055016214     PISSN: 02505991     EISSN: 09737138     Source Type: Journal    
DOI: 10.1007/s12038-011-9101-6     Document Type: Article

References (25)

1. WC Cho 2007 Contribution of oncoproteomics to cancer biomarker discovery Mol Cancer 6 25 17407558 10.1186/1476-4598-6-25 (Pubitemid 46605013)
2. MA Comunale M Lowman RE Long J Krakover R Philip S Seeholzer AA Evans HW Hann TM Block AS Mehta 2006 Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma J. Proteome Res. 5 308 315 16457596 10.1021/pr050328x 1:CAS:528:DC%2BD28XlvFSg (Pubitemid 43224256)
3. HB El-Serag KL Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2557 2576 17570226 10.1053/j.gastro.2007.04.061 1:CAS:528:DC%2BD2sXnvFOgsrw%3D (Pubitemid 46890874)
4. PA Farazi RA DePinho 2006 Hepatocellular carcinoma pathogenesis: from genes to environment Nat. Rev. Cancer 6 674 687 16929323 10.1038/nrc1934 1:CAS:528:DC%2BD28XosVOmsLs%3D (Pubitemid 44286000)
5. JT Feng S Shang L Beretta 2006 Proteomics for the early detection and treatment of hepatocellular carcinoma Oncogene 25 3810 3817 16799622 10.1038/sj.onc.1209551 1:CAS:528:DC%2BD28XmtFCntLw%3D (Pubitemid 43980476)
6. HR Gentry AU Singer L Betts C Yang JD Ferrara J Sondek LV Parise 2005 Structural and biochemical characterization of CIB1 delineates a new family of EF-hand-containing proteins J. Biol. Chem. 280 8407 8415 15574431 10.1074/jbc.M411515200 1:CAS:528:DC%2BD2MXhs1yhs7o%3D (Pubitemid 40349745)
7. A Gorg W Postel J Weser S Gunther JR Strahler SM Hanash L Somerlot 1987 Elimination of point straking on silver-stained two-dimensional gels by addition of iodoacetamide to the equilibration buffer Electrophoresis 8 122 124 10.1002/elps.1150080207
8. LH Hwang 2006 Gene therapy strategies for hepatocellular carcinoma J. Biomed. Sci. 13 453 468 16633742 10.1007/s11373-006-9085-7 1:CAS:528: DC%2BD28XpsVCisLg%3D
9. JC Kostyak UP Naik 2011 Calcium- and integrin-binding protein 1 regulates endomitosis and its interaction with polo-like kinase 3 is enhanced in endomitotic dami cells PLoS One 6 e14513 21264284 10.1371/journal.pone.0014513 1:CAS:528:DC%2BC3MXhtFWnt7Y%3D
10. X Liu Y Cheng W Sheng H Lu Y Xu, et al. 2010 Clinicopathologic features and prognostic factors in alpha-fetoprotein-producing gastric cancers: analysis of 104 cases J. Surg. Oncol. 102 249 255 20740583 10.1002/jso.21624
11. T Maass I Sfakianakis F Staib M Krupp PR Galle A Teufel 2010 Microarray-based gene expression analysis of hepatocellular carcinoma Curr. Genomics 11 261 268 21119890 10.2174/138920210791233063 1:CAS:528: DC%2BC3cXmsF2ms7k%3D
12. H Minagawa M Honda K Miyazaki Y Tabuse R Teramoto, et al. 2008 Comparative proteomic and transcriptomic profiling of the human hepatocellular carcinoma Biochem. Biophys. Res. Commun. 366 186 192 18060859 10.1016/j.bbrc.2007.11.101 1:CAS:528:DC%2BD2sXhsVOktr7F (Pubitemid 350297227)
13. EF Petricoin KC Zoon EC Kohn JC Barrett LA Liotta 2002 Clinical proteomics: translating benchside promise into bedside reality Nat. Rev. Drug Discov. 1 683 695 12209149 10.1038/nrd891 1:CAS:528:DC%2BD38Xmslamtrg%3D (Pubitemid 37361543)
14. T Rabilloud C Adessi A Giraudel J Lunardi 1997 Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients Electrophoresis 18 307 316 9150907 10.1002/elps.1150180303 1:CAS:528:DyaK2sXjtlGnt70%3D (Pubitemid 27174413)
15. Raza SA, Clifford GM and Franceschi S 2007 Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br. J. Cancer. 96 1127-134 (Pubitemid 46608308)
16. RC Ryther AS Flynt JA Phillips 3rd JG Patton 2005 siRNA therapeutics: big potential from small RNAs Gene Ther. 12 5 11 15496962 10.1038/sj.gt.3302356 1:CAS:528:DC%2BD2cXhtVOmsr%2FO (Pubitemid 40090039)
17. W Sun B Xing Y Sun X Du M Lu, et al. 2007 Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues Mol. Cell Proteomic. 6 1798 1808 10.1074/mcp.M600449-MCP200 1:CAS:528:DC%2BD2sXht1WksbvM (Pubitemid 350031681)
18. PL Tseng MH Tai CC Huang CC Wang JW Lin, et al. 2008 Overexpression of VEGF is associated with positive p53 immunostaining in hepatocellular carcinoma (HCC) and adverse outcome of HCC patients J. Surg. Oncol. 98 349 357 18646041 10.1002/jso.21109
19. F Wang S Kaur LG Cavin M Arsura 2008 Nuclear-factor-kappaB (NF-kappaB) and radical oxygen species play contrary roles in transforming growth factor-beta1 (TGF-beta1)-induced apoptosis in hepatocellular carcinoma (HCC) cells Biochem. Biophys. Res. Commun. 377 1107 1112 18983820 10.1016/j.bbrc.2008. 10.130 1:CAS:528:DC%2BD1cXhsVGhu73M
20. X Wang Y Chen QB Han CY Chan H Wang, et al. 2009 Proteomic identification of molecular targets of gambogic acid: role of stathmin in hepatocellular carcinoma Proteomics 9 242 253 19086098 10.1002/pmic.200800155 1:CAS:528:DC%2BD1MXhvVSisrY%3D
21. C White J Yang MJ Monteiro JK Foskett 2006 CIB1, a ubiquitously expressed Ca2+-binding protein ligand of the InsP3 receptor Ca2+ release channel J. Biol. Chem. 281 20825 20833 16723353 10.1074/jbc.M602175200 1:CAS:528: DC%2BD28Xnt1GqtLw%3D (Pubitemid 44115424)
22. JD Wulfkuhle LA Liotta EF Petricoin 2003 Proteomic applications for the early detection of cancer Nat. Rev. Cancer 3 267 275 12671665 10.1038/nrc1043 1:CAS:528:DC%2BD3sXisFajt7g%3D (Pubitemid 37328862)
23. KW Yoon JH Cho JK Lee YH Kang JS Chae, et al. 2009 CIB1 functions as a Ca(2+)-sensitive modulator of stress-induced signaling by targeting ASK1 Proc. Natl. Acad. Sci. USA 106 17389 17394 19805025 10.1073/pnas.0812259106 1:CAS:528:DC%2BD1MXhs1WktrbM
24. W Yuan TM Leisner AW McFadden Z Wang MK Larson, et al. 2006 CIB1 is an endogenous inhibitor of agonist-induced integrin alphaIIbbeta3 activation J. Cell Biol. 172 169 175 16418530 10.1083/jcb.200505131 1:CAS:528: DC%2BD28XntV2jtw%3D%3D (Pubitemid 43112965)
25. MA Zayed W Yuan D Chalothorn JE Faber LV Parise 2010 Tumor growth and angiogenesis is impaired in CIB1 knockout mice J. Angiogenes Res. 2 17 20804551 10.1186/2040-2384-2-17